Cita APA

Kirabo, A., Park, S. O., Majumder, A., Gali, M., Reinhard, M. K., Wamsley, H. L., . . . Sayeski, P. P. (2011). The Jak2 Inhibitor, G6, Alleviates Jak2-V617F-Mediated Myeloproliferative Neoplasia by Providing Significant Therapeutic Efficacy to the Bone Marrow. Neoplasia Press Inc.

Citación estilo Chicago

Kirabo, Annet, et al. The Jak2 Inhibitor, G6, Alleviates Jak2-V617F-Mediated Myeloproliferative Neoplasia By Providing Significant Therapeutic Efficacy to the Bone Marrow. Neoplasia Press Inc, 2011.

Cita MLA

Kirabo, Annet, et al. The Jak2 Inhibitor, G6, Alleviates Jak2-V617F-Mediated Myeloproliferative Neoplasia By Providing Significant Therapeutic Efficacy to the Bone Marrow. Neoplasia Press Inc, 2011.